Peralta Galo, Sánchez M Blanca, Garrido J Carlos, De Benito Inés, Cano M Eliecer, Martínez-Martínez Luis, Roiz M Pía
Internal Medicine Service, Sierrallana Hospital, Barrio de Ganzo s/n, Torrelavega, Cantabria, Spain.
J Antimicrob Chemother. 2007 Oct;60(4):855-63. doi: 10.1093/jac/dkm279. Epub 2007 Jul 20.
Escherichia coli is the most frequent Gram-negative organism causing bacteraemia. There are few data about prognostic factors of bloodstream infections due to E. coli. In particular, the consequences of antibiotic resistance and of adequate empirical antibiotic treatment on outcome remain broadly unknown.
We conducted a retrospective cohort study of patients with E. coli bacteraemia between January 1997 and June 2005 to identify any association between antibiotic resistance, adequacy of empirical antibiotic therapy and mortality.
Of 663 patients with E. coli bacteraemia, 36 (5.4%) died. Patients with multidrug-resistant (MDR) E. coli bacteraemia had a significantly lower frequency of correct empirical antibiotic treatment than patients with non-MDR E. coli bacteraemia [relative risk (RR) 0.53; 95% confidence interval (CI) 0.48-0.67], and also had a significantly higher mortality (RR 3.31; 95% CI 1.72-6.36). An association between the number of antibiotics to which E. coli was resistant with adequacy of empirical antibiotic (P < 0.001) and with mortality (P < 0.001) was detected. After adjustment for other significant risk factors and confounders, the inadequacy of empirical antibiotic treatment was associated with an increased mortality (adjusted OR 2.98; 95% CI 1.25-7.11). When the adequacy of empirical treatment was excluded from the model, the presence of MDR E. coli in blood cultures was also associated with the prognosis (adjusted OR 3.11; 95% CI 1.3-7.44). In multivariate analysis, other variables associated with the outcome were age, the presence of severe sepsis or shock, Charlson index score and a non-urinary origin of the bacteraemia.
Adequacy of empirical antibiotic treatment is an independent risk factor for mortality in patients with E. coli bacteraemia. MDR E. coli bacteraemia had a worse prognosis due, at least in part, to a lower frequency of correct empirical treatment.
大肠杆菌是引起菌血症最常见的革兰氏阴性菌。关于大肠杆菌所致血流感染的预后因素的数据较少。特别是,抗生素耐药性及充分的经验性抗生素治疗对预后的影响仍大致不明。
我们对1997年1月至2005年6月期间患有大肠杆菌菌血症的患者进行了一项回顾性队列研究,以确定抗生素耐药性、经验性抗生素治疗的充分性与死亡率之间的任何关联。
在663例大肠杆菌菌血症患者中,36例(5.4%)死亡。多重耐药(MDR)大肠杆菌菌血症患者接受正确经验性抗生素治疗的频率显著低于非MDR大肠杆菌菌血症患者[相对危险度(RR)0.53;95%置信区间(CI)0.48 - 0.67],且死亡率也显著更高(RR 3.31;95% CI 1.72 - 6.36)。检测到大肠杆菌对其耐药的抗生素数量与经验性抗生素的充分性(P < 0.001)及死亡率(P < 0.001)之间存在关联。在对其他显著风险因素和混杂因素进行调整后,经验性抗生素治疗不充分与死亡率增加相关(调整后的比值比2.98;95% CI 1.25 - 7.11)。当模型中排除经验性治疗的充分性时,血培养中存在MDR大肠杆菌也与预后相关(调整后的比值比3.11;95% CI 1.3 - 7.44)。在多变量分析中,与预后相关的其他变量包括年龄、严重脓毒症或休克的存在、查尔森指数评分以及菌血症的非泌尿系统来源。
经验性抗生素治疗的充分性是大肠杆菌菌血症患者死亡率的一个独立危险因素。MDR大肠杆菌菌血症预后较差,至少部分原因是正确经验性治疗的频率较低。